here, we have tested the hypothesis that ffas are the link between obesity and insulin resistance/hyperinsulinemia and that, therefore, lowering of chronically elevated plasma ffa levels would improve insulin resistance/hyperinsulinemia and glucose tolerance in obese nondiabetic and diabetic subjects.